Recommendations for the diagnosis and treatment of the acute porphyrias. - Wikidata - wikimedia - TriplyDB

Recommendations for the diagnosis and treatment of the acute porphyrias.

Recommendations for the diagnosis and treatment of the acute porphyrias.

http://www.wikidata.org/entity/Q33985744

about

An update of clinical management of acute intermittent porphyria Acute Hepatic Porphyria Erythroid heme biosynthesis and its disorders Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse Neuroglobin, a Factor Playing for Nerve Cell Survival Heme deficiency in Alzheimer's disease: a possible connection to porphyria Role of delta-aminolevulinic acid in the symptoms of acute porphyria RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2alpha kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone A 22-year-old woman with abdominal pain.Heme acts through the Bach1b/Nrf2a-MafK pathway to regulate exocrine peptidase precursor genes in porphyric zebrafish First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans Hemin-activated macrophages home to the pancreas and protect from acute pancreatitis via heme oxygenase-1 induction Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda.Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage.Heme oxygenase-1 is induced in peripheral blood mononuclear cells of patients with acute pancreatitis: a potential therapeutic target Acute intermittent porphyria caused by novel mutation in HMBS gene, misdiagnosed as cholecystitis.Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal.Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria mice.Clinically important features of porphyrin and heme metabolism and the porphyrias.Acute intermittent porphyria associated with respiratory failure: a multidisciplinary approach.Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells.Acute porphyria in a patient with Arnold Chiari malformation.Cardiac calcification in acute intermittent porphyria A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen.Carbon monoxide reverses diabetic gastroparesis in NOD mice.Schizoaffective disorder with missed diagnosis of acute porphyria: a case report and overview.Liver transplantation in the management of porphyria.A method for determining δ-aminolevulinic acid synthase activity in homogenized cells and tissues.Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium.Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome and lateralized periodic discharges plus fast activity on EEG.One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias.Dual porphyrias revisited.Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of Liver transplantation for porphyria: who, when, and how?Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification.Circadian rhythms in acute intermittent porphyria--a pilot study.

P2860

Q26781152-6EECFD87-2F4D-4B27-BDD5-D887D57FE2C8 Q26781776-CBF0AFFA-E9E5-400F-A858-E5A62566DAAC Q27008081-F6ED32F7-519B-493A-8B9E-F0A97E919699 Q27307650-0714F4E6-C64C-4150-ABAA-0E66A4773AEF Q28069727-21CBB05B-AACF-46FD-AA87-630A6D922FED Q28200784-8A59A863-4169-42E4-8D4E-5E8F9FC070DB Q28388495-B353D701-EF75-434F-9C1D-383E786C2CFB Q33694417-D531BFA6-4EF7-4A0B-8E65-F45DAA5AD81E Q33754847-34030768-AD54-4F77-9310-C92B46069971 Q33770233-52F1CFBF-1242-478B-8AC9-C2CEF09F6C4E Q33814251-2818BA38-DD3D-4669-808E-05B0A9646918 Q34003346-932627D6-4445-4A01-B52D-D19A1789CF85 Q34084504-DD8D8E8C-E1AB-444A-B4E5-CDA680886151 Q34300246-E94F4473-F99C-47A3-AAAE-FAB79D68E45A Q34456999-E2B15F93-2FA5-4D73-AF5B-D6224D37EA6E Q34513592-F23787FE-3197-40AE-A679-D0ECAB748DDA Q34532174-480F2C91-8912-4710-A9A7-EB1874AD9521 Q34555359-1555C79A-A04E-4BDA-ADA7-6E2FD8B212E3 Q34556835-B9241AE0-FE7D-4C25-B923-09FE68AB6E3C Q34785744-F71F466C-B4DE-45CA-B6A2-CBD9F9250956 Q35039960-A9D39EA7-7195-48D3-B0A6-ADE78DFC8656 Q35128157-6240F5F5-6FCE-4EC1-9CFE-0FF7D301663B Q35128606-FA4FCB53-BBD9-4AC7-9F8A-1B0FCD402569 Q35234490-A920AB71-0998-42AC-ACE4-A6A549C8151D Q35714854-6B48E795-AAB9-4C7D-BA98-B875A1339EFC Q35771543-6AB416D1-FB8F-4908-A93B-8DD97E90EBAE Q35833280-EE3A7A36-BB1D-4EDD-9460-D8347EECAB17 Q35838589-5AEB0F61-1765-4B39-A53A-7BDC659F8045 Q35908900-876049CF-8F41-49FA-9537-6D8C41C69F1A Q36040689-F3432C70-0529-43FF-9D85-BED8DD2FAAC0 Q36142293-C89D30FF-9404-4218-9287-41BA6449702E Q36143730-4B0BA51F-4F11-49CA-A698-B82EB61D6DAC Q36267789-79055E15-ED31-4AF9-A95F-42D03BDBF60E Q36319508-C55A8111-BF9F-4C67-B5DE-659C5E15655A Q36388073-357B9100-40E8-4124-B97B-B3F661DD6452 Q36553696-0121F113-09A8-4DCC-8D1D-09CB2074996E Q36821528-E453DB7D-4443-4407-A4D4-C34E11EC20D9 Q36925703-236D95D0-0C40-448E-A3C5-B22C7A9CFDA3 Q36928112-9FB55DD4-A3FE-467B-AAEC-455B619ECBE3 Q36942335-8729438E-23B5-4109-9611-50574BC97DD3

P2860

Recommendations for the diagnosis and treatment of the acute porphyrias.

http://www.wikidata.org/entity/Q33985744

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Recommendations for the diagnosis and treatment of the acute porphyrias.

@ast

Recommendations for the diagnosis and treatment of the acute porphyrias.

@en

type

label

Recommendations for the diagnosis and treatment of the acute porphyrias.

@ast

Recommendations for the diagnosis and treatment of the acute porphyrias.

@en

prefLabel

Recommendations for the diagnosis and treatment of the acute porphyrias.

@ast

Recommendations for the diagnosis and treatment of the acute porphyrias.

@en

P1433

Q33985744-FFB49773-6950-442B-B4D9-4DCF0C00F050

P1476

Q33985744-26996C5C-535D-499F-9D6B-0E89A220E3F7

P2093

Q33985744-020A03CA-D8B8-46DE-9D2A-21261B3872E0

Q33985744-11875590-F93B-4029-89A1-70589B066D23

Q33985744-7CE27A1E-E68C-41BF-AD77-1AA2F85CBF1F

Q33985744-89044E25-BA43-4E23-B83D-70CF2E2B19F8

Q33985744-8F51A461-A6F9-4D68-BD5D-2C85B2DF1D84

Q33985744-AB3CB0A1-DE8A-4CA7-A5F1-51BF69A4524E

Q33985744-B477DF80-A747-4FB1-B6A7-11ED0130D43C

P304

Q33985744-499ECC90-1BEC-474A-9FC7-7FD7719F5013

P31

Q33985744-ECBFC932-3218-44E5-ACEA-B86DEE6F06B0

P356

Q33985744-60F9F8B7-1EBB-4E8B-A814-FF7909A2AB0C

P407

Q33985744-4F20D672-E4E7-4E15-914B-A4E4C503F611

P433

Q33985744-FAAF9B97-9B98-4EF9-80F1-CCA806A17EE5

P478

Q33985744-418999F0-45CF-477E-8525-2832751E4745

P577

Q33985744-CE2B7676-228E-400B-8E53-D279EB604B12

P698

Q33985744-1DD59CA5-14BF-445C-9E9C-49ED08AD9B46

P356

0003-4819-142-6-200503150-00010

P1433

Annals of Internal Medicine

P1476

Recommendations for the diagnosis and treatment of the acute porphyrias.

@en

P2093

Claus A Pierach

http://www.w3.org/2001/XMLSchema#string

Herbert L Bonkovsky

http://www.w3.org/2001/XMLSchema#string

James P Kushner

http://www.w3.org/2001/XMLSchema#string

Joseph R Bloomer

http://www.w3.org/2001/XMLSchema#string

Karl E Anderson

http://www.w3.org/2001/XMLSchema#string

Neville R Pimstone

http://www.w3.org/2001/XMLSchema#string

Robert J Desnick

http://www.w3.org/2001/XMLSchema#string

P304

439-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-142-6-200503150-00010

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

142

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15767622

http://www.w3.org/2001/XMLSchema#string